Market Research Report
Global Eubiotics Market Research and Forecast, 2019-2025
|Global Eubiotics Market Research and Forecast, 2019-2025|
Published: February 9, 2019
Orion Market Research Pvt Ltd
Delivery time: 2-3 business days
Eubiotics Market Size, Share & Trends Analysis Report, By Type (Probiotics, Prebiotics, Exogenous Enzymes, Organic Acids, Essential Oils, and Others), By Application (Feed Additives, Food & Beverages and Dietary Supplements), and Forecast, 2019-2025.
Eubiotics refers to maintain a balance of microflora (algae, bacteria, and fungi) in the gastrointestinal tract. The products of eubiotics, such as probiotics, prebiotics, and organic acids promote the growth and health of livestock animals by modulating their gut flora. In addition, there are a significant number of microbes that cause intestinal diseases among humans. These microbes include parasites (Entamoeba, Giardia, and Ascaris), viruses (Rotaviruses, and Norwalk agent), and bacteria (Clostridium, Campylobacter, Shigella, Salmonella and E. coli). According to UK Government, infectious intestinal diseases affect 1 in 5 people annually and the symptoms are not limited to vomiting and diarrhea in UK. The eubiotics products, such as probiotics can be consumed in fermented foods, such as yogurt, kefir, and sauerkraut or in supplement form. The consumption of probiotics may support boost the number of healthy bacteria. Probiotics that have found to offer health benefits comprise several strains of Lactobacillus, Saccharomyces and Bifidobacterium. This enables keeping gut healthy and improves the immune system.
Moreover, irritable bowel syndrome (IBS) is one of the most common intestinal disorder which is highly difficult to treat. Probiotic supplements, primarily those with Bifidobacterium infantis may alleviate symptoms of IBS, such as bowel movement irregularity, abdominal pain and bloating. The consumption of probiotics prevents complications from use of antibiotics, including antibiotics-associated diarrhea. Hence, it is also recommended by doctors to the patients. This, in turn, is encouraging the growth of the market. Moreover, increasing demand for dietary supplements and partnerships for development of eubiotics products are boosting the global eubiotics market.
The global eubiotics market is segmented on the basis of type, application, and end-user. On the basis of type, the market is further segmented into probiotics, prebiotics, exogenous enzymes, organic acids, essential oils, and others. Based on application, the market is further classified into feed additives, food & beverages and dietary supplements. Significant adoption of dietary supplements has witnessed over the years. For instance, according to the 2016 Council for Responsible Nutrition (CRN) survey, 71% of the US adults take dietary supplements. Probiotics are used as a dietary supplement that supports intestinal balance and reducing gastrointestinal inflammation. Moreover, shifting towards a healthy lifestyle is primarily encouraging the use of eubiotics in dietary supplementation. Based on end-user, the market is further classified into animals and humans.
Geographically, the global eubiotics market is classified into four key regions, includes North America, Europe, Asia-Pacific, and RoW. The crucial factors affecting the growth of the market in North America include increasing demand for dietary supplements coupled with the adoption of a healthy lifestyle. Europe is showing significant growth in the market due to significant awareness about the safety of animals and the prevention of diseases. However, Asia-Pacific is estimated to witness optimistic growth due to rising consumption of meat.
The major companies working in the market comprise E.I. du Pont de Nemours, Koninklijke DSM N.V., Abbott Laboratories, Inc., Novozymes A/S and Co., and Cargill, Inc. Several strategies have been followed by these companies to expand market share globally. These strategies include merger and acquisitions, product launches, partnership and collaborations and amongst others. For instance, in December 2017, Koninklijke DSM NV acquired BioCare Copenhagen A/S, a Danish bio-venture firm specialized in food supplements that involves targeting gastrointestinal disorders, microbial compounds, immunity, and infections. With this acquisition, the company aimed to expand its offerings in gut health ingredients with probiotics for immune health and digestive health.
The market study of global eubiotics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.
The report is intended for government and private companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers and initial norms. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Global eubiotics market is segmented on the basis of regional outlook and following segments:
GLOBAL EUBIOTICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)